Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001072613-02-000401
Filing Date
2002-02-28
Accepted
2002-02-28 00:00:00
Documents
9
Period of Report
2001-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR YEAR ENDED NOVEMBER 30, 2001 form10-k_11071.txt 10-K 94485
3 RESTRICTED STOCK AGREEMENT exhibit10-1_11071.txt EX-10.1 5946
4 LOAN AGREEMENT exhibit10-2_11071.txt EX-10.2 61021
5 STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS exhibit11_11071.txt EX-11 3320
6 2001 ANNUAL REPORT exhibit13_11071.txt EX-13 202962
7 SUBSIDIARIES OF THE COMPANY exhibit21_11071.txt EX-21 700
8 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS exhibit23_11071.txt EX-23 700
9 REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS exhibit27-1_11071.txt EX-99.27.1 1223
10 SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS exhibit27-2_11071.txt EX-99.27.2 1479
  Complete submission text file 0001072613-02-000401.txt   374517
Mailing Address 1715 W 38TH ST CHATTANOOGA TN 37409
Business Address 1715 W 38TH ST CHATTANOOGA TN 37409 4238214571
CHATTEM INC (Filer) CIK: 0000019520 (see all company filings)

EIN.: 620156300 | State of Incorp.: TN | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-05905 | Film No.: 02562834
SIC: 2834 Pharmaceutical Preparations